Text Size
1061 studies found for:    Endometrial Cancer: Clinical Trials

Modify this search | How to Use Search Results

Show Display Options
Download search resultsDownload the search results for:
Endometrial Cancer: Clinical Trials (1061 records)
Need help? See Downloading Content for Analysis
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Recruiting Trial Between Two Follow up Regimens With Different Test Intensity in Endometrial Cancer Treated Patients
Condition: Endometrial Cancer
Interventions: Procedure: Intensive/Low-Risk Treatment (IA G1; IA G2);   Procedure: Intensive/High-Risk Treatment (≥ IA G3);   Procedure: Minimalist/Low-Risk Treatment (IA G1; IA G2);   Procedure: Minimalist/High-Risk Treatment (≥ IA G3)
2 Active, not recruiting Patient, Physician, and Nurse Factors Associated With Entry Onto Clinical Trials and Finishing Treatment in Patients With Primary or Recurrent Uterine, Endometrial, or Cervical Cancer
Conditions: Cervical Cancer;   Endometrial Cancer;   Sarcoma
Interventions: Other: communication analysis;   Other: medical chart review;   Other: questionnaire administration;   Other: study of socioeconomic and demographic variables
3 Active, not recruiting The Study of Oral Steroid Sulphatase Inhibitor BN83495 Versus Megestrol Acetate (MA) in Women With Advanced or Recurrent Endometrial Cancer
Condition: Endometrial Cancer
Interventions: Drug: BN83495;   Drug: Megestrol Acetate (MA)
4 Recruiting Phase Ib Trial of Folate Binding Protein Vaccine in Ovarian Cancer
Conditions: Ovarian Cancer;   Endometrial Cancer
Interventions: Biological: E39 peptide vaccine;   Other: Clinical tracking for disease progression/recurrence
5 Completed Study of EC145 in Patients With Advanced Ovarian and Endometrial Cancers
Conditions: Ovarian Cancer;   Endometrial Cancer
Intervention: Drug: EC145
6 Recruiting Safety, PK of AKT and MEK Combination
Condition: Cancer
Interventions: Drug: GSK1120212;   Drug: GSK2141795
7 Active, not recruiting Risk Factors for Endometrial Cancer in Black Women
Condition: Endometrial Cancer
Interventions: Other: questionnaire administration;   Other: study of socioeconomic and demographic variables;   Procedure: evaluation of cancer risk factors
8 Recruiting An Endometrial Cancer Chemoprevention Study of Metformin
Condition: Gynecology
Interventions: Drug: Metformin;   Other: Placebo;   Procedure: Endometrial Biopsy;   Behavioral: Lifestyle Intervention;   Behavioral: Questionnaires
9 Recruiting Pilot Study Using a PET Gamma Probe to Evaluate Lymph Nodes in Endometrial Cancer
Condition: Endometrial Cancer
Interventions: Procedure: lymphadenectomy;   Procedure: therapeutic conventional therapy;   Procedure: Positron Emission Tomography/ Computed Tomography;   Radiation: fludeoxyglucose F 18
10 Not yet recruiting A Study of XL184 (Cabozantinib) in Endometrial Cancer
Conditions: Metastatic;   Endometrial Cancer;   Endometrioid;   Serous;   Mix Histology;   Carcinosarcoma;   Clear Cell;   Adenosquamous
Intervention: Drug: XL-184
11 Recruiting A Study Of Two Dual PI3K/mTOR Inhibitors, PF-04691502 And PF-05212384 In Patients With Recurrent Endometrial Cancer
Condition: Endometrial Neoplasms
Intervention: Drug: PF-05212384
12 Completed Radiation Therapy or Observation Only in Treating Patients With Endometrial Cancer Who Have Undergone Surgery
Condition: Endometrial Cancer
Intervention: Radiation: radiation therapy
13 Completed A Study of Letrozole in the Treatment of Endometrial Cancer
Condition: Recurrent and Metastatic Endometrial Cancer
Intervention: Drug: Letrozole
14 Completed CCI-779 in Treating Patients With Metastatic or Locally Advanced Recurrent Endometrial Cancer
Condition: Endometrial Cancer
Intervention: Drug: temsirolimus
15 Terminated Feasibility Study: Accuracy of Biomarker in Detection of Endometrial Cancer
Conditions: Uterine Cancer;   Endometrial Cancer
Intervention: Procedure: P2X7 Assay
16 Not yet recruiting Study Comparing AEZS-108 to Doxorubicin as a Second Line Therapy of Endometrial Cancer
Condition: Endometrial Cancer
Interventions: Drug: AEZS-108 / zoptarelin doxorubicin;   Drug: doxorubicin
17 Completed Surgery Plus Medroxyprogesterone in Preventing Endometrial Cancer
Condition: Endometrial Cancer
Intervention: Drug: medroxyprogesterone
18 Unknown † Study of Genes and the Environment in Patients With Endometrial Cancer in the East Anglia, Oxford, Trent, or West Midlands Regions of the United Kingdom
Condition: Endometrial Cancer
Interventions: Genetic: polymorphism analysis;   Other: laboratory biomarker analysis;   Other: questionnaire administration
19 Completed Clinical Trial of Ridaforolimus Compared to Progestin or Chemotherapy for Advanced Endometrial Carcinoma (MK-8669-007 AM6)
Condition: Endometrial Cancer
Interventions: Drug: ridaforolimus;   Drug: medroxyprogesterone acetate tablets OR megestrol acetate;   Drug: chemotherapy
20 Recruiting Randomized Trial of Radiation Therapy With or Without Chemotherapy for Endometrial Cancer
Condition: Endometrial Cancer
Interventions: Radiation: Radiation Therapy;   Drug: cisplatin;   Drug: carboplatin;   Drug: Paclitaxel
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years